Prot #HBS-101-CL-001: An Open Label Expanded Access Program Intended to Provide Treatment with HBS-101 (Pitolisant) to Adult Patients in the U.S. with Excessive Daytime Sleepiness Associated with Narcolepsy with or without Cataplexy

Project: Research project

Project Details

StatusFinished
Effective start/end date5/30/18 → 5/30/21

Funding

  • Parexel (Prot #HBS-101-CL-001 // Prot #HBS-101-CL-001)
  • Harmony Biosciences, LLC (Prot #HBS-101-CL-001 // Prot #HBS-101-CL-001)